Finance
UK medical devices group Niox halts sale after Keensight backs out
Published by Global Banking & Finance Review®
Posted on April 11, 2025
1 min readLast updated: January 24, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on April 11, 2025
1 min readLast updated: January 24, 2026
Niox Group halted its sale after Keensight Capital withdrew due to economic challenges. The UK economy remains vulnerable amid global trade tensions.
(Reuters) -Niox Group has halted its sale process after suitor Keensight Capital withdrew its interest in making a buyout offer due to challenging macroeconomic conditions, the British medical device maker said on Friday.
In March, Paris-based private equity firm Keensight proposed acquiring Niox Group for 22.4 million pounds ($29.1 million) - or 81 pence per share - higher than its initial bid of 78 pence per share.
However, the escalating trade war sparked by sweeping tariffs from U.S. President Donald Trump's administration has disrupted the global order and increased the likelihood of a recession.
The UK remains particularly vulnerable to the fallout as an open economy with a large financial sector, the Bank of England warned this week.
Niox had said in March that while it was in discussions with other potential parties interested in making an offer, it was inclined to recommend Keensight's proposal to its shareholders, pending a firm offer.
($1 = 0.7697 pounds)
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)
The main topic is Niox Group halting its sale process after Keensight Capital withdrew its buyout offer due to economic challenges.
Keensight Capital withdrew its offer due to challenging macroeconomic conditions and the impact of global trade tensions.
The UK economy is particularly vulnerable to the fallout from global trade tensions, as warned by the Bank of England.
Explore more articles in the Finance category
